Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. Chiba, S

    1. Selective inhibition by a class III antiarrhythmic agent, E-4031, of the negative chronotropic response to parasympathetic stimulation in anesthetized dogs.
      H Imamura, Y Furukawa, H Nakano, M Kasama, Y Hoyano and S Chiba
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 467-472;

  2. Chiou, W J

    1. Pharmacological characterization of A-127722: an orally active and highly potent ETA-selective receptor antagonist.
      T J Opgenorth, A L Adler, S V Calzadilla, W J Chiou, B D Dayton, D B Dixon, L J Gehrke, L Hernandez, S R Magnuson, K C Marsh, E I Novosad, T W Von Geldern, J L Wessale, M Winn and J R Wu-Wong
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 473-481;

  3. Choi, O H

    1. Sustained activation of phospholipase D via adenosine A3 receptors is associated with enhancement of antigen- and Ca(2+)-ionophore-induced secretion in a rat mast cell line.
      H Ali, O H Choi, P F Fraundorfer, K Yamada, H M Gonzaga and M A Beaven
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 837-845;

  4. Chou, C

    1. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.
      R Lew, K E Sabol, C Chou, G L Vosmer, J Richards and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 855-865;

  5. Chung, S J

    1. Saturable disposition of taurine in the rat cerebrospinal fluid.
      S J Chung, V K Ramanathan, C M Brett and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 676-682;

  6. Ciceri, S

    1. Effects of single and short-term administration of clonidine on hypothalamic-pituitary somatotropic function of the adult male rat: an in situ hybridization study.
      V De Gennaro Colonna, M Zoli, B P Settembrini, S Ciceri, A De Marco, S G Cella, L F Agnati and E E Muller
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 795-800;

  7. Cieslinski, L B

    1. Prolonged beta adrenoceptor stimulation up-regulates cAMP phosphodiesterase activity in human monocytes by increasing mRNA and protein for phosphodiesterases 4A and 4B.
      C D Manning, M M McLaughlin, G P Livi, L B Cieslinski, T J Torphy and M S Barnette
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 810-818;

  8. Cipris, S

    1. A G protein, not cyclic AMP, mediates effects of VIP on the inwardly rectifying K+ channels in endothelial cells.
      E A Pasyk, S Cipris and E E Daniel
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 690-696;

  9. Coe, I R

    1. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol.
      I R Coe, D P Dohrman, A Constantinescu, I Diamond and A S Gordon
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 365-369;

  10. Constantinescu, A

    1. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol.
      I R Coe, D P Dohrman, A Constantinescu, I Diamond and A S Gordon
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 365-369;
« Previous (Pages : 1 2 3 4 5 6 7 8 9 10 ... 31) Next »
Back to top

In this issue

Advertisement